X-linked myotubular myopathy in Rottweiler dogs is caused by a missense mutation in Exon 11 of the MTM1 gene

BackgroundCongenital and inherited myopathies in dogs are faithful models of human muscle diseases and are being recognized with increasing frequency. In fact, canine models of dystrophin deficient muscular dystrophy and X-linked myotubular myopathy are of tremendous value in the translation of new and promising therapies for the treatment of these diseases. We have recently identified a family of Australian Rottweilers in which male puppies were clinically affected with severe muscle weakness and atrophy that resulted in early euthanasia or death. X-linked myotubular myopathy was suspected based on the early and severe clinical presentation and histopathological changes within muscle biopsies. The aim of this study was to determine the genetic basis for myopathy in these dogs and compare and contrast the clinical presentation, histopathology, ultrastructure, and mutation in this family of Rottweiler dogs with the previously described myotubular myopathy in Labrador retrievers.ResultsHistopathology, histochemistry, and ultrastructural examination of muscle biopsies from affected Rottweiler puppies were consistent with an X-linked myotubular myopathy. An unusual finding that differed from the previously reported Labradors and similar human cases was the presence of excessive autophagy and prominent autophagic vacuoles. Molecular investigations confirmed a missense mutation in exon 11 of MTM1 that was predicted to result in a non-functional phosphatase activity. Although the clinical presentations and histopathology were similar, the MTM1 p.(Q384P) mutation is different from the p.(N155K) mutation in exon 7 affecting Labrador retrievers with X-linked myotubular myopathy.ConclusionsHere we describe a second pathogenic mutation in MTM1 causing X-linked myotubular myopathy in dogs. Our findings suggest a variety of MTM1 mutations in dogs as seen in human patients. The number of MTM1 mutations resulting in similar severe and progressive clinical myopathy and histopathological changes are likely to increase as canine myopathies are further characterized.

[1]  T. Noda,et al.  Modulation of Local PtdIns3P Levels by the PI Phosphatase MTMR3 Regulates Constitutive Autophagy , 2010, Traffic.

[2]  L. Kunkel,et al.  MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers , 2010, Proceedings of the National Academy of Sciences.

[3]  J. Mcguire,et al.  Observations on Normal Skeletal Muscle of Mature Dogs: A Cytochemical, Histochemical, and Morphometric Study , 1982, Veterinary pathology.

[4]  V. Dubowitz,et al.  Histological and Histochemical Stains and Reactions , 2020, Muscle Biopsy.

[5]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[6]  K. Braund,et al.  Hereditary Myopathy in Labrador Retrievers: A Morphologic Study , 1986, Veterinary pathology.

[7]  G. Shelton,et al.  A possible new inherited myopathy in a young Labrador retriever. , 2008, The Canadian veterinary journal = La revue veterinaire canadienne.

[8]  P. Majerus,et al.  The role of myotubularin-related phosphatases in the control of autophagy and programmed cell death. , 2012, Advances in biological regulation.

[9]  M. Sternberg,et al.  SuSPect: Enhanced Prediction of Single Amino Acid Variant (SAV) Phenotype Using Network Features , 2014, Journal of molecular biology.

[10]  G. Shelton,et al.  Centronuclear myopathy in a Border collie dog. , 2012, The Journal of small animal practice.

[11]  T. Proikas-Cezanne,et al.  Control of autophagy initiation by phosphoinositide 3‐phosphatase jumpy , 2009, The EMBO journal.

[12]  S. Eades,et al.  Suspected Congenital Centronuclear Myopathy in an Arabian‐cross Foal , 2014, Journal of veterinary internal medicine.

[13]  J. Mandel,et al.  Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin‐proteasome pathways , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Krawczak,et al.  Genotype–phenotype correlations in X-linked myotubular myopathy , 2002, Neuromuscular Disorders.

[15]  Andrew P. Vreede,et al.  Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy , 2009, PLoS genetics.

[16]  W. Ollier,et al.  Factors influencing the antibody response of dogs vaccinated against rabies. , 2007, Vaccine.

[17]  B. Payrastre,et al.  Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo , 2013, Journal of Cell Science.

[18]  A. Beggs,et al.  Clinical utility gene card for: Centronuclear and myotubular myopathies , 2012, European Journal of Human Genetics.

[19]  R. Grange,et al.  Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy , 2014, Science Translational Medicine.

[20]  I. Nonaka,et al.  Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle , 2008, Neuromuscular Disorders.

[21]  S. Szmigielski,et al.  Morphology and function of liver after intravenous and intraportal injections of the immunomodulating agent Propionibacterium granulosum. , 1984, Experimental pathology.

[22]  K. Claeys,et al.  “Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy , 2009, Acta Neuropathologica.

[23]  Straub,et al.  RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.

[24]  Jocelyn Laporte,et al.  Mutation spectrum in the large GTPase dynamin 2, and genotype–phenotype correlation in autosomal dominant centronuclear myopathy , 2012, Human mutation.

[25]  Jeffrey A. Porter,et al.  Defective Autophagy and mTORC1 Signaling in Myotubularin Null Mice , 2012, Molecular and Cellular Biology.

[26]  P. Majerus,et al.  Myotubularin-related protein (MTMR) 9 determines the enzymatic activity, substrate specificity, and role in autophagy of MTMR8 , 2012, Proceedings of the National Academy of Sciences.

[27]  D. Mellor,et al.  Inherited myopathy of great Danes. , 2006, The Journal of small animal practice.

[28]  A. Bolino,et al.  Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. , 2012, Trends in molecular medicine.

[29]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[30]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[31]  A. Beggs,et al.  X-Linked Myotubular and Centronuclear Myopathies , 2005, Journal of neuropathology and experimental neurology.

[32]  J. Thibaud,et al.  Centronuclear Myopathy in Labrador Retrievers: A Recent Founder Mutation in the PTPLA Gene Has Rapidly Disseminated Worldwide , 2012, PloS one.

[33]  A. Buj-Bello,et al.  T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase , 2009, Proceedings of the National Academy of Sciences.

[34]  L. Amoasii,et al.  Primary T-tubule and autophagy defects in the phosphoinositide phosphatase Jumpy/MTMR14 knockout mice muscle. , 2012, Advances in biological regulation.

[35]  S. Klauck,et al.  A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast , 1996, Nature Genetics.

[36]  J. T. Dunnen,et al.  Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database , 2012, European Journal of Human Genetics.

[37]  S. Blot,et al.  SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. , 2005, Human molecular genetics.

[38]  Jocelyn Laporte,et al.  Amphiphysin 2 (BIN1) in physiology and diseases , 2014, Journal of Molecular Medicine.

[39]  Ching H. Wang,et al.  Approach to the diagnosis of congenital myopathies , 2014, Neuromuscular Disorders.

[40]  S. Carpenter,et al.  THE EFFECT OF VINCRISTINE ON SKELETAL MUSCLE IN THE RAT: A Correlative Histochemical, Ultrastructural and Chemical Study , 1972, Journal of neuropathology and experimental neurology.

[41]  J. Dixon,et al.  Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. , 2003, Molecular cell.